Skip to main content
Erschienen in: World Journal of Surgery 4/2013

01.04.2013

Factors Influencing the Success of In Vivo Sentinel Lymph Node Procedure in Colon Cancer Patients

Swiss Prospective, Multicenter Study Sentinel Lymph Node Procedure in Colon Cancer

verfasst von: Carsten T. Viehl, Ulrich Guller, Igor Langer, Urban Laffer, Daniel Oertli, Markus Zuber

Erschienen in: World Journal of Surgery | Ausgabe 4/2013

Einloggen, um Zugang zu erhalten

Abstract

Background

The sentinel lymph node (SLN) procedure has the potential to provide relevant improvement in nodal staging in colon cancer patients. However, there remains room for improvement for SLN identification and sensitivity. Therefore, the objective of the present investigation was to analyze factors influencing the success of the SLN procedure in colon cancer patients.

Methods

One hundred seventy-four consecutive colon cancer patients were prospectively enrolled in this multicenter study and underwent in vivo SLN procedure with isosulfan blue 1 % followed by open standard oncologic colon resection. Several patient-, tumor-, and procedure-related factors possibly influencing the SLN identification and sensitivity were analyzed.

Results

Sentinel lymph node identification rate and accuracy were 89.1 and 83.9 %, respectively. Successful identification of SLN was significantly associated with the intraoperative visualization of blue lymphatic vessels (p < 0.001) and with female gender (p = 0.024). True positive SLN results were significantly associated with higher numbers of SLN (p = 0.026) and with pN2 stage (p = 0.004). There was a trend toward better sensitivity in patients with lower body mass index (BMI) (p = 0.050).

Conclusions

The success of the SLN procedure in colon cancer patients depends on both procedure-related factors (intraoperative visualization of blue lymphatic vessels, high number of SLN identified) and patient factors (gender, BMI). While patient factors can not be influenced, intraoperative visualization of blue lymphatics and identification of high numbers of SLN are key for a successful SLN procedure.
Literatur
1.
Zurück zum Zitat Bembenek AE, Rosenberg R, Wagler E et al (2007) Sentinel lymph node biopsy in colon cancer: a prospective multicenter trial. Ann Surg 245:858–863PubMedCrossRef Bembenek AE, Rosenberg R, Wagler E et al (2007) Sentinel lymph node biopsy in colon cancer: a prospective multicenter trial. Ann Surg 245:858–863PubMedCrossRef
2.
Zurück zum Zitat Bilchik AJ, DiNome M, Saha S et al (2006) Prospective multicenter trial of staging adequacy in colon cancer: preliminary results. Arch Surg 141:527–533PubMedCrossRef Bilchik AJ, DiNome M, Saha S et al (2006) Prospective multicenter trial of staging adequacy in colon cancer: preliminary results. Arch Surg 141:527–533PubMedCrossRef
3.
Zurück zum Zitat Kelder W, Braat AE, Karrenbeld A et al (2007) The sentinel node procedure in colon carcinoma: a multi-centre study in The Netherlands. Int J Colorectal Dis 22:1509–1514PubMedCrossRef Kelder W, Braat AE, Karrenbeld A et al (2007) The sentinel node procedure in colon carcinoma: a multi-centre study in The Netherlands. Int J Colorectal Dis 22:1509–1514PubMedCrossRef
4.
Zurück zum Zitat Saha S, Seghal R, Patel M et al (2006) A multicenter trial of sentinel lymph node mapping in colorectal cancer: prognostic implications for nodal staging and recurrence. Am J Surg 191:305–310PubMedCrossRef Saha S, Seghal R, Patel M et al (2006) A multicenter trial of sentinel lymph node mapping in colorectal cancer: prognostic implications for nodal staging and recurrence. Am J Surg 191:305–310PubMedCrossRef
5.
Zurück zum Zitat van der Pas MH, Meijer S, Hoekstra OS et al (2011) Sentinel-lymph-node procedure in colon and rectal cancer: a systematic review and meta-analysis. Lancet Oncol 12:540–550PubMedCrossRef van der Pas MH, Meijer S, Hoekstra OS et al (2011) Sentinel-lymph-node procedure in colon and rectal cancer: a systematic review and meta-analysis. Lancet Oncol 12:540–550PubMedCrossRef
6.
Zurück zum Zitat Viehl CT, Guller U, Cecini R et al (2012) Sentinel lymph node procedure leads to upstaging of patients with resectable colon cancer: results of the Swiss prospective, multicenter study sentinel lymph node procedure in colon cancer. Ann Surg Oncol 19:1959–1965PubMedCrossRef Viehl CT, Guller U, Cecini R et al (2012) Sentinel lymph node procedure leads to upstaging of patients with resectable colon cancer: results of the Swiss prospective, multicenter study sentinel lymph node procedure in colon cancer. Ann Surg Oncol 19:1959–1965PubMedCrossRef
7.
Zurück zum Zitat Stojadinovic A, Nissan A, Protic M et al (2007) Prospective randomized study comparing sentinel lymph node evaluation with standard pathologic evaluation for the staging of colon carcinoma: results from the United States Military Cancer Institute Clinical Trials Group Study GI-01. Ann Surg 245:846–857PubMedCrossRef Stojadinovic A, Nissan A, Protic M et al (2007) Prospective randomized study comparing sentinel lymph node evaluation with standard pathologic evaluation for the staging of colon carcinoma: results from the United States Military Cancer Institute Clinical Trials Group Study GI-01. Ann Surg 245:846–857PubMedCrossRef
9.
Zurück zum Zitat Tuech JJ, Pessaux P, Di Fiore F et al (2006) Sentinel node mapping in colon carcinoma: in-vivo versus ex-vivo approach. Eur J Surg Oncol 32:158–161PubMedCrossRef Tuech JJ, Pessaux P, Di Fiore F et al (2006) Sentinel node mapping in colon carcinoma: in-vivo versus ex-vivo approach. Eur J Surg Oncol 32:158–161PubMedCrossRef
10.
Zurück zum Zitat Hutteman M, Choi HS, Mieog JS et al (2011) Clinical translation of ex vivo sentinel lymph node mapping for colorectal cancer using invisible near-infrared fluorescence light. Ann Surg Oncol 18:1006–1014PubMedCrossRef Hutteman M, Choi HS, Mieog JS et al (2011) Clinical translation of ex vivo sentinel lymph node mapping for colorectal cancer using invisible near-infrared fluorescence light. Ann Surg Oncol 18:1006–1014PubMedCrossRef
11.
Zurück zum Zitat Langer I, Guller U, Berclaz G et al (2007) Morbidity of sentinel lymph node biopsy (SLN) alone versus SLN and completion axillary lymph node dissection after breast cancer surgery: a prospective Swiss multicenter study on 659 patients. Ann Surg 245:452–461PubMedCrossRef Langer I, Guller U, Berclaz G et al (2007) Morbidity of sentinel lymph node biopsy (SLN) alone versus SLN and completion axillary lymph node dissection after breast cancer surgery: a prospective Swiss multicenter study on 659 patients. Ann Surg 245:452–461PubMedCrossRef
12.
Zurück zum Zitat Nissan A, Protic M, Bilchik AJ et al (2012) United States Military Cancer Institute Clinical Trials Group (USMCI GI-01) randomized controlled trial comparing targeted nodal assessment and ultrastaging with standard pathological evaluation for colon cancer. Ann Surg 256:412–427PubMedCrossRef Nissan A, Protic M, Bilchik AJ et al (2012) United States Military Cancer Institute Clinical Trials Group (USMCI GI-01) randomized controlled trial comparing targeted nodal assessment and ultrastaging with standard pathological evaluation for colon cancer. Ann Surg 256:412–427PubMedCrossRef
13.
Zurück zum Zitat Nissan A, Protic M, Bilchik A et al (2010) Predictive model of outcome of targeted nodal assessment in colorectal cancer. Ann Surg 251:265–274PubMedCrossRef Nissan A, Protic M, Bilchik A et al (2010) Predictive model of outcome of targeted nodal assessment in colorectal cancer. Ann Surg 251:265–274PubMedCrossRef
Metadaten
Titel
Factors Influencing the Success of In Vivo Sentinel Lymph Node Procedure in Colon Cancer Patients
Swiss Prospective, Multicenter Study Sentinel Lymph Node Procedure in Colon Cancer
verfasst von
Carsten T. Viehl
Ulrich Guller
Igor Langer
Urban Laffer
Daniel Oertli
Markus Zuber
Publikationsdatum
01.04.2013
Verlag
Springer-Verlag
Erschienen in
World Journal of Surgery / Ausgabe 4/2013
Print ISSN: 0364-2313
Elektronische ISSN: 1432-2323
DOI
https://doi.org/10.1007/s00268-013-1910-3

Weitere Artikel der Ausgabe 4/2013

World Journal of Surgery 4/2013 Zur Ausgabe

Update Chirurgie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

S3-Leitlinie „Diagnostik und Therapie des Karpaltunnelsyndroms“

Karpaltunnelsyndrom BDC Leitlinien Webinare
CME: 2 Punkte

Das Karpaltunnelsyndrom ist die häufigste Kompressionsneuropathie peripherer Nerven. Obwohl die Anamnese mit dem nächtlichen Einschlafen der Hand (Brachialgia parästhetica nocturna) sehr typisch ist, ist eine klinisch-neurologische Untersuchung und Elektroneurografie in manchen Fällen auch eine Neurosonografie erforderlich. Im Anfangsstadium sind konservative Maßnahmen (Handgelenksschiene, Ergotherapie) empfehlenswert. Bei nicht Ansprechen der konservativen Therapie oder Auftreten von neurologischen Ausfällen ist eine Dekompression des N. medianus am Karpaltunnel indiziert.

Prof. Dr. med. Gregor Antoniadis
Berufsverband der Deutschen Chirurgie e.V.

S2e-Leitlinie „Distale Radiusfraktur“

Radiusfraktur BDC Leitlinien Webinare
CME: 2 Punkte

Das Webinar beschäftigt sich mit Fragen und Antworten zu Diagnostik und Klassifikation sowie Möglichkeiten des Ausschlusses von Zusatzverletzungen. Die Referenten erläutern, welche Frakturen konservativ behandelt werden können und wie. Das Webinar beantwortet die Frage nach aktuellen operativen Therapiekonzepten: Welcher Zugang, welches Osteosynthesematerial? Auf was muss bei der Nachbehandlung der distalen Radiusfraktur geachtet werden?

PD Dr. med. Oliver Pieske
Dr. med. Benjamin Meyknecht
Berufsverband der Deutschen Chirurgie e.V.

S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“

Appendizitis BDC Leitlinien Webinare
CME: 2 Punkte

Inhalte des Webinars zur S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“ sind die Darstellung des Projektes und des Erstellungswegs zur S1-Leitlinie, die Erläuterung der klinischen Relevanz der Klassifikation EAES 2015, die wissenschaftliche Begründung der wichtigsten Empfehlungen und die Darstellung stadiengerechter Therapieoptionen.

Dr. med. Mihailo Andric
Berufsverband der Deutschen Chirurgie e.V.